Tavros Therapeutics Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
22
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$50.4M
Tavros Therapeutics General Information
Description
Developer of oncological drugs designed to treat cancer. The company's drug can impact oncology therapy by uncovering vulnerabilities within the tumor and placing the right drug with the right combination, enabling patients to get cured of oncological disease.
Contact Information
Website
www.tavrostx.comCorporate Office
- 8 Davis Drive
- Suite 100
- Durham, NC 27709
- United States
Corporate Office
- 8 Davis Drive
- Suite 100
- Durham, NC 27709
- United States
Tavros Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 23-Dec-2024 | $50.4M | Completed | Generating Revenue | ||
| 2. Seed Round | 27-Sep-2022 | Completed | Clinical Trials - General | |||
| 1. Seed Round | 17-Mar-2020 | $3M | $3M | Completed | Clinical Trials - General |
Tavros Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Tavros Therapeutics Comparisons
Industry
Financing
Details
Tavros Therapeutics Competitors (60)
One of Tavros Therapeutics’s 60 competitors is Ability Pharma, a Private Equity-Backed company based in Cerdanyola, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Invectys | Venture Capital-Backed | Houston, TX | ||||
| Cirius Therapeutics | Venture Capital-Backed | Grand Rapids, MI | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Dragonfly (Drug Discovery) | Venture Capital-Backed | Waltham, MA |
Tavros Therapeutics Signals
Tavros Therapeutics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| KdT Ventures | Venture Capital | Minority | ||
| Piedmont Capital Investments | Venture Capital | Minority |
Tavros Therapeutics FAQs
-
When was Tavros Therapeutics founded?
Tavros Therapeutics was founded in 2019.
-
Where is Tavros Therapeutics headquartered?
Tavros Therapeutics is headquartered in Durham, NC.
-
What is the size of Tavros Therapeutics?
Tavros Therapeutics has 22 total employees.
-
What industry is Tavros Therapeutics in?
Tavros Therapeutics’s primary industry is Drug Discovery.
-
Is Tavros Therapeutics a private or public company?
Tavros Therapeutics is a Private company.
-
What is the current valuation of Tavros Therapeutics?
The current valuation of Tavros Therapeutics is .
-
What is Tavros Therapeutics’s current revenue?
The current revenue for Tavros Therapeutics is .
-
How much funding has Tavros Therapeutics raised over time?
Tavros Therapeutics has raised $10.5M.
-
Who are Tavros Therapeutics’s investors?
Alexandria Venture Investments, KdT Ventures, and Piedmont Capital Investments have invested in Tavros Therapeutics.
-
Who are Tavros Therapeutics’s competitors?
Ability Pharma, Invectys, Cirius Therapeutics, Inovio Pharmaceuticals, and Dragonfly (Drug Discovery) are some of the 60 competitors of Tavros Therapeutics.
-
When was Tavros Therapeutics acquired?
Tavros Therapeutics was acquired on 23-Dec-2024.
-
Who acquired Tavros Therapeutics?
Tavros Therapeutics was acquired by Vividion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process